Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)
$6.02
+0.0500 ( +0.84% ) 75.5K
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Market Data
Open
$6.02
Previous close
$5.97
Volume
75.5K
Market cap
$77.88M
Day range
$5.94 - $6.12
52 week range
$3.21 - $23.52
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 10, 2024 |
8-k | 8K-related | 13 | May 29, 2024 |
8-k | 8K-related | 14 | May 22, 2024 |
8-k | 8K-related | 14 | May 15, 2024 |
nt | Quarterly Reports | 1 | May 10, 2024 |
8-k | 8K-related | 15 | Apr 12, 2024 |
nt | Quarterly Reports | 1 | Mar 18, 2024 |
8-k | 8K-related | 18 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
8-k | 8K-related | 15 | Mar 01, 2024 |